Pharmaron Beijing Co Ltd
SZSE:300759

Watchlist Manager
Pharmaron Beijing Co Ltd Logo
Pharmaron Beijing Co Ltd
SZSE:300759
Watchlist
Price: 31.41 CNY -0.44% Market Closed
Market Cap: 46.7B CNY
Have any thoughts about
Pharmaron Beijing Co Ltd?
Write Note

Pharmaron Beijing Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pharmaron Beijing Co Ltd
Cost of Revenue Peer Comparison

Comparables:
603259
2269
300347
M
688114
W
2268

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Pharmaron Beijing Co Ltd
SZSE:300759
Cost of Revenue
-ÂĄ7.7B
CAGR 3-Years
-25%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Cost of Revenue
-ÂĄ23.3B
CAGR 3-Years
-23%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Cost of Revenue
-ÂĄ10.5B
CAGR 3-Years
-38%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Cost of Revenue
-ÂĄ4.4B
CAGR 3-Years
-29%
CAGR 5-Years
-24%
CAGR 10-Years
-35%
M
MGI Tech Co Ltd
SSE:688114
Cost of Revenue
-ÂĄ1.4B
CAGR 3-Years
-25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
W
WuXi XDC Cayman Inc
HKEX:2268
Cost of Revenue
-ÂĄ1.6B
CAGR 3-Years
-161%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Pharmaron Beijing Co Ltd's Cost of Revenue?
Cost of Revenue
-7.7B CNY

Based on the financial report for Jun 30, 2024, Pharmaron Beijing Co Ltd's Cost of Revenue amounts to -7.7B CNY.

What is Pharmaron Beijing Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-28%

Over the last year, the Cost of Revenue growth was -7%. The average annual Cost of Revenue growth rates for Pharmaron Beijing Co Ltd have been -25% over the past three years , -28% over the past five years .

Back to Top